We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 11, 2020

First-Line Panitumumab + Capecitabine in Older Patients With Wild-Type RAS Metastatic Colorectal Cancer

Journal of Geriatric Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Geriatric Oncology
First-Line Panitumumab Plus Capecitabine for the Treatment of Older Patients With Wild-Type RAS Metastatic Colorectal Cancer. The Phase II, PANEL study
J Geriatr Oncol 2020 Jun 21;[EPub Ahead of Print], JC Méndez Méndez, M Salgado Fernández, J de la Cámara Gómez, ML Pellón Augusto, M Covela Rua, G Quintero Aldana, A Fernández Montes, M Reboredo López, M Valladares Ayerbes, M Jorge Fernández, P González Villarroel, C Romero Reinoso, M Ramos Vázquez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading